Repro-Med Systems (OTCMKTS:REPR) and Invo Bioscience (OTCMKTS:IVOB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.


This table compares Repro-Med Systems and Invo Bioscience’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Repro-Med Systems 2.38% 12.29% 10.30%
Invo Bioscience -585.49% N/A -117.54%

Volatility & Risk

Repro-Med Systems has a beta of -0.79, suggesting that its share price is 179% less volatile than the S&P 500. Comparatively, Invo Bioscience has a beta of -0.75, suggesting that its share price is 175% less volatile than the S&P 500.

Institutional & Insider Ownership

17.7% of Repro-Med Systems shares are owned by institutional investors. Comparatively, 0.0% of Invo Bioscience shares are owned by institutional investors. 40.0% of Repro-Med Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Repro-Med Systems and Invo Bioscience, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Repro-Med Systems 0 0 0 0 N/A
Invo Bioscience 0 0 0 0 N/A

Earnings & Valuation

This table compares Repro-Med Systems and Invo Bioscience’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Repro-Med Systems $17.35 million 3.57 $910,000.00 N/A N/A
Invo Bioscience $490,000.00 116.40 -$3.08 million N/A N/A

Repro-Med Systems has higher revenue and earnings than Invo Bioscience.


Repro-Med Systems beats Invo Bioscience on 7 of the 9 factors compared between the two stocks.

About Repro-Med Systems

Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

About Invo Bioscience

INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts.

Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with's FREE daily email newsletter.